Unternehmen Curative Biotechnology, Inc. Other OTC
Aktien
A1CWHT
US20786Q2093
CTYX
Biotechnologie
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
I. Garr
CEO | Chief Executive Officer | 71 | 11.02.21 |
Paul M. Michael
CHM | Chairman | - | - |
Steve Chizzik
IRC | Investor Relations Contact | - | - |
Ron Bordens
PRN | Corporate Officer/Principal | - | 11.02.21 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Cary Sucoff
BRD | Director/Board Member | 71 | 12.05.22 |
Theresa Heah
BRD | Director/Board Member | 46 | 31.03. |
Lawrence Zaslow
BRD | Director/Board Member | - | - |
Paul M. Michael
CHM | Chairman | - | - |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 0 | 227 000 | 0 | 0 | 99,94 % |
Aktie B | 1 | 903 263 385 | 902 756 978 ( 99,94 %) | 0 | |
Aktie C | 0 | 30 000 000 | 0 | 0 |
Unternehmenskontakt
Curative Biotechnology, Inc.
3801 PGA Boulevard Suite 600
33410, Palm Beach Gardens
+
http://www.curativebiotech.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+44.48% | 54.04 Mrd. | |
+43.57% | 41.96 Mrd. | |
-0.86% | 41.92 Mrd. | |
-7.59% | 28.35 Mrd. | |
+12.30% | 26.35 Mrd. | |
-21.83% | 19 Mrd. | |
+7.15% | 13 Mrd. | |
+29.40% | 12.28 Mrd. | |
+25.15% | 12.19 Mrd. |